Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Common clinical substitutions enhance the carbapenemase activity of OXA-51-like class D β-lactamases from Acinetobacter spp.

Literature DB >> 25155607

Common clinical substitutions enhance the carbapenemase activity of OXA-51-like class D β-lactamases from Acinetobacter spp.

Joshua M Mitchell¹, David A Leonard².

Abstract

Mesh：

Substances：

Year: 2014 PMID： 25155607 PMCID： PMC4249439 DOI： 10.1128/AAC.03651-14

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

× No keyword cloud information.

13 in total

1. Protein structure prediction on the Web: a case study using the Phyre server.

Authors: Lawrence A Kelley; Michael J E Sternberg
Journal: Nat Protoc Date: 2009 Impact factor: 13.491

2. Association between β-lactamase-encoding bla(OXA-51) variants and DiversiLab rep-PCR-based typing of Acinetobacter baumannii isolates.

Authors: Esther Zander; Alexandr Nemec; Harald Seifert; Paul G Higgins
Journal: J Clin Microbiol Date: 2012-03-14 Impact factor: 5.948

3. Crystal structure of the carbapenemase OXA-24 reveals insights into the mechanism of carbapenem hydrolysis.

Authors: Elena Santillana; Alejandro Beceiro; Germán Bou; Antonio Romero
Journal: Proc Natl Acad Sci U S A Date: 2007-03-20 Impact factor: 11.205

4. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors: Y Cheng; W H Prusoff
Journal: Biochem Pharmacol Date: 1973-12-01 Impact factor: 5.858

5. The sequences of seven class D beta-lactamases isolated from carbapenem-resistant Acinetobacter baumannii from four continents.

Authors: S Brown; S G B Amyes
Journal: Clin Microbiol Infect Date: 2005-04 Impact factor: 8.067

6. Conversion of OXA-66 into OXA-82 in clinical Acinetobacter baumannii isolates and association with altered carbapenem susceptibility.

Authors: Esther Zander; Agnieszka Chmielarczyk; Piotr Heczko; Harald Seifert; Paul G Higgins
Journal: J Antimicrob Chemother Date: 2012-09-26 Impact factor: 5.790

7. Loss of a 29-kilodalton outer membrane protein in Acinetobacter baumannii is associated with imipenem resistance.

Authors: Adriana S Limansky; María Alejandra Mussi; Alejandro M Viale
Journal: J Clin Microbiol Date: 2002-12 Impact factor: 5.948

8. Emergence and Distribution of Plasmids Bearing the blaOXA-51-like gene with an upstream ISAba1 in carbapenem-resistant Acinetobacter baumannii isolates in Taiwan.

Authors: Te-Li Chen; Yi-Tzu Lee; Shu-Chen Kuo; Po-Ren Hsueh; Feng-Yee Chang; Leung-Kei Siu; Wen-Chien Ko; Chang-Phone Fung
Journal: Antimicrob Agents Chemother Date: 2010-08-16 Impact factor: 5.191

9. Structures of the class D Carbapenemases OXA-23 and OXA-146: mechanistic basis of activity against carbapenems, extended-spectrum cephalosporins, and aztreonam.

Authors: Kip-Chumba J Kaitany; Neil V Klinger; Cynthia M June; Maddison E Ramey; Robert A Bonomo; Rachel A Powers; David A Leonard
Journal: Antimicrob Agents Chemother Date: 2013-07-22 Impact factor: 5.191

Review 10. OXA β-lactamases.

Authors: Benjamin A Evans; Sebastian G B Amyes
Journal: Clin Microbiol Rev Date: 2014-04 Impact factor: 26.132

11 in total

1. The structure of a doripenem-bound OXA-51 class D β-lactamase variant with enhanced carbapenemase activity.

Authors: Cynthia M June; Taylor J Muckenthaler; Emma C Schroder; Zachary L Klamer; Zdzislaw Wawrzak; Rachel A Powers; Agnieszka Szarecka; David A Leonard
Journal: Protein Sci Date: 2016-09-26 Impact factor: 6.725

2. Genetic and Biochemical Characterization of OXA-519, a Novel OXA-48-Like β-Lactamase.

Authors: Laura Dabos; Pierre Bogaerts; Remy A Bonnin; Agustin Zavala; Pierre Sacré; Bogdan I Iorga; Daniel T Huang; Youri Glupczynski; Thierry Naas
Journal: Antimicrob Agents Chemother Date: 2018-07-27 Impact factor: 5.191

3. Clinical Variants of the Native Class D β-Lactamase of Acinetobacter baumannii Pose an Emerging Threat through Increased Hydrolytic Activity against Carbapenems.

Authors: Emma C Schroder; Zachary L Klamer; Aysegul Saral; Kyle A Sugg; Cynthia M June; Troy Wymore; Agnieszka Szarecka; David A Leonard
Journal: Antimicrob Agents Chemother Date: 2016-09-23 Impact factor: 5.191

4. Multiple substitutions lead to increased loop flexibility and expanded specificity in Acinetobacter baumannii carbapenemase OXA-239.

Authors: Thomas M Harper; Cynthia M June; Magdalena A Taracila; Robert A Bonomo; Rachel A Powers; David A Leonard
Journal: Biochem J Date: 2018-01-11 Impact factor: 3.857

5. Multicenter Study of the Relationship between Carbapenem MIC Values and Clinical Outcome of Patients with Acinetobacter Bacteremia.

Authors: Ya-Sung Yang; Yung-Chih Wang; Shu-Chen Kuo; Chung-Ting Chen; Chang-Pan Liu; Yuag-Meng Liu; Te-Li Chen; Yi-Tzu Lee
Journal: Antimicrob Agents Chemother Date: 2017-08-24 Impact factor: 5.191

6. SISPA-Seq for rapid whole genome surveys of bacterial isolates.

Authors: Meredith S Wright; Timothy B Stockwell; Erin Beck; Dana A Busam; Saralee Bajaksouzian; Michael R Jacobs; Robert A Bonomo; Mark D Adams
Journal: Infect Genet Evol Date: 2015-03-19 Impact factor: 3.342

7. Use of Comparative Genomics To Characterize the Diversity of Acinetobacter baumannii Surveillance Isolates in a Health Care Institution.

Authors: Lalena Wallace; Sean C Daugherty; Sushma Nagaraj; J Kristie Johnson; Anthony D Harris; David A Rasko
Journal: Antimicrob Agents Chemother Date: 2016-09-23 Impact factor: 5.191